Submitted by Anonymous (not verified) on 21 January 2026 - 15:38
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 7, Status: Authorised